EX-23.1 3 tenx_ex231.htm CONSENTS OF EXPERTS AND COUNSEL Blueprint
 
Exhibit 23.1
 
Consent of Independent Registered Public Accounting Firm
 
 
We consent to the incorporation by reference in this Registration Statement on Form S-8, of our report dated April 1, 2019, relating to the consolidated financial statements of Tenax Therapeutics, Inc. (the “Company”), appearing in the Annual Report on Form 10-K of the Company for the year ended December 31, 2018.
 
 
/s/ CHERRY BEKAERT LLP
 
Raleigh, North Carolina
August 30, 2019